Celularity Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
/ 
Frequently asked questions
To buy Celularity Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Celularity Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Celularity Inc. is CELU:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Celularity Inc. has its primary listing on NASDAQ (Small cap). You can trade Celularity Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Celularity Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Celularity Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Celularity Inc..